GCM
ACLS icon

Gallacher Capital Management’s Axcelis ACLS Stock Holding History

Gallacher Capital Management’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,455
Closed -$257K – 288
2024
Q3 		$257K Buy
+2,455
New +$287K 0.12% 224
2024
Q2 		– Sell
-3,340
Closed -$372K – 269
2024
Q1 		$372K Sell
3,340
-297
-8% -$35.4K 0.19% 143
2023
Q4 		$472K Buy
3,637
+1,699
+88% +$234K 0.26% 75
2023
Q3 		$316K Buy
1,938
+41
+2% +$7.21K 0.2% 130
2023
Q2 		$348K Sell
1,897
-294
-13% -$42.3K 0.2% 140
2023
Q1 		$292K Sell
2,191
-1,837
-46% -$216K 0.18% 164
2022
Q4 		$320K Buy
+4,028
New +$284K 0.19% 120

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Reinhart Partners
Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Gallacher Capital Management's ACLS Position: Q4 2024 in Review

Gallacher Capital Management sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 2,455 shares — an estimated $257K sold.

Gallacher Capital Management first reported a position in ACLS in Q4 2022 and held it in 7 quarters. The position peaked at $472K in Q4 2023. 325 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Gallacher Capital Management reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Gallacher Capital Management sold 2,455 Axcelis shares in Q4 2024, an estimated $257K.
  • Gallacher Capital Management first reported a position in Axcelis in Q4 2022 and held it in 7 quarters.
  • Gallacher Capital Management's Axcelis position peaked at $472K in Q4 2023.
  • 325 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Gallacher Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.